Research Topics

Integrated Cancer Centers represent the new model for the management of solid and haematological cancers all over the world. They integrate the different professionals into a vast system, which includes public health specialists, fundamental, translational and clinical research, as well as healthcare teams involved in diagnosis and treatment. The CRTOH adopted this innovated model, and is also part of an ambitious initiative taking place in Western Switzerland that aims to designates “poles of excellence”, to, ultimately, ensure the best possible care for patients.

Full Members 


Bourquin_copie_web.png
Immunopharmacology of Cancer
Prof. Carole Bourquin, Department of Anaesthesiology, Pharmacology, Intensive Care and Emergencies, Faculty of Medicine & Pharmaceutical Sciences, Faculty of Science

Cohen_web.png
Gynaecological Tumours and Development Biology
Prof. Marie Cohen, Department of Paediatrics, Gynaecology and Obstetrics, Faculty of Medicine
Dermitzakis_crtoh.png

Population Genomics and Genetics of Complex Traits
Prof. Emmanouil Dermitzakis, Department of Genetic Medicine and Development, Faculty of Medicine

Dietrich_web.png Cancer Immunotherapy
Prof. Pierre-Yves Dietrich, Department of Medicine, Faculty of Medicine & Head of the Division of Oncology, HUG

Foti_web.png
Molecular mechanisms of fatty liver disease progression to hepatocellular carcinoma
Prof. Michelangelo Foti, Department of Cell Physiology and Metabolism, Faculty of Medicine

Gotta_web.png
Cell Division and Develoment
Prof. Monica Gotta, Department of Cell Physiology and Metabolism, Faculty of Medicine
Hugues_web.png

Lymphatic vessels in the regulation of tumor immunity
Prof. Stéphanie Hugues, Department of Pathology and Immunology,

Faculty of Medicine


Katanaev_web.png
Oncogenic signaling pathways: from fundamental research to drug discovery
Vladimir Katanaev, Department of Cell Physiology and Metabolism, Faculty of Medicine

Labidi-Galy_web.png
Pathogenesis and precision medicine in breast and ovarian cancer
Dr. Intidhar Labidi-Galy, Department of Medicine, Faculty of Medicine & Division of Oncology, HUG

Matthes_web.png
Lymphoma and Leukemia
Prof. Thomas Matthes, Department of Medicine, Faculty of Medicine & Division of Haematology, HUG

Mach_web.png
Translational Research in Oncology
Prof. Nicolas Mach, Department of Medicine, Faculty of Medicine  &   in charge of Fondation Dr Henri Dubois-Ferrière Dinu Lipatti Clinical Research Unit, HUG

Meraldi_web.png

Cell Division and Cancer
Prof. Patrick Meraldi, Department of Cell Physiology and Metabolism, Faculty of Medicine

Migliorini_web.png

Brain Tumor and Immune Cell Engineering Group – BTICE Group
Prof. Denis Migliorini, ISERC Foundation Chair in Immunotherapies of Brain Tumours, Department of Medicine, Faculty of Medicine, Department of Oncology, HUG

Pittet_bandeau_web.png

Understanding and manipulating the immune system to fight against cancer
Prof. Mikäel PITTET, ISREC Foundation Chair in onco-immunology ,Department of Pathology and Immunology, Faculty of Medicine, Department of Oncology, HUG


Tamburini_web.png
Lymphomas and leukaemias
Prof. Jérôme Tamburini, Department of Medicine, Faculty of Medicine & Department of Oncology, HUG

Tsantoulis_2_web.png

Precision oncology
Dr. Petros Tsantoulis, Department of Medicine, Faculty of Medicine & Department of Oncology, HUG


Toso_web.png

Liver Cancer
Prof. Christian Toso, Department of Surgery, Faculty of Medicine & Division of Transplant Surgery, HUG


Walker_small.png

Immunobiology of Brain Tumours
Dr Paul Walker, Department of Medicine, Faculty of Medicine & Division of Oncology, HUG

Associated Members


Borchard_web.png 
Biopharmaceuticals
Prof. Gerrit Borchard
, Pharmaceutical Sciences, Faculty of Science

Nowak_web.png
Molecular Pharmacology
Prof. Patrycja Nowak-Sliwinska
, Pharmaceutical Sciences, Faculty of Science

Cuendet_web.png

Pharmacognosy
Prof. Muriel Cuendet, Pharmaceutical Sciences, Faculty of Science